ACE2 and COVID-19: Clinical studies on hospitalized patients have suggesteda positive correlation between plasma ACE2 levels and the severityof COVID-19 infection, while ACE2 deficiencymay also worsen long COVID-19 symptoms, especially in patients withunderlying conditions such as diabetes, hypertension and heart disease.